Abha Bommireddi

Abha Bommireddi is an experienced professional in program and portfolio management within the biopharmaceutical industry, currently serving as the Executive Vice President of Program and Portfolio Management at Protagonist Therapeutics since April 2017. Prior roles include Senior Vice President and Vice President of Program Management at the same company, as well as Senior Director and Vice President of Project and Portfolio Management at Principia Biopharma from December 2012 to March 2017. Abha's extensive experience in project management also includes positions at Elan, Talima Therapeutics, Onyx Pharmaceuticals, Proteolix, Ilypsa (acquired by Amgen), and FibroGen. Early career contributions were made at the FDA as a Consumer Safety Officer and at Abbott Laboratories as a Senior Research Scientist. Abha Bommireddi holds a Master's degree in Pharmaceutics from the University of Missouri-Kansas City and a Bachelor's degree in Pharmacy from Kundnani College of Pharmacy.